Replies to post #111529 on Biotech Values

[microcapfun]

>>How many reps will it take to sell Carfilzomib? I can't imagine much more than 100.<<

I agree - for the U.S. Onyx says they want to market Carfilzomib in Europe as well.

>>you don't need more than one drug to be profitable, you just need the right drug. I guess we'll see if carfilzomib is the right drug.<<

Agreed, rkrw. Carfilzomib is certainly a potential blockbuster. My only point was it is always good for the bottom line to have the same sales force selling multiple products to the same docs - and there won't be much of that happening with Nexavar and Carfilzomib.

micro